Company Overview and News
I was in the middle of it, Mr. Pinstripe Suit, topped by a nifty fedora. I was also the skunk at the garden party, warning that the end was near, that the boom would bust. When it did bust, and I heard the first stories of ruined young dot-com millionaires, I laughed.
The net cash position is down to only $26.3 billion not including a large tax liability.
Plain and simple: the term is outdated. A lot of large-cap familiar names are still called “blue-chip stock” when they are nothing of the kind. If you can’t rid the term “blue-chip stock” from your lexicon, then it should at least apply to a whole new stream of companies.
As Bitcoin, Litecoin, Ethereum, and Bitcoin Cash become more mainstream, people are looking for alternatives to invest in.
The company already shows an impressive list of clients such as IBM, Facebook, Oracle and Verizon.
The good news is that the fiscal third quarter earnings report Cisco Systems, Inc. (NASDAQ:CSCO) posted Wednesday afternoon could have been worse. The bad news is that the outlook for the current quarter could have been better. Investors, seeing the glass as half empty rather than half full, sent CSCO stock lower to the tune of 4%.
The following slide deck was published by International Business Machines Corporation in conjunction with this event.
A month has gone by since the last earnings report for International Business Machines Corporation (IBM - Free Report) . Shares have lost about 10.7% in that time frame.
There’s a seeming contradiction when it comes to Apple Inc. (NASDAQ:AAPL). Apple stock now sits just off an all-time high. Last Thursday, its market capitalization hit $934 billion — the highest ever for a U.S. company. The iPhone is the most profitable product ever created — and it’s driven huge returns in AAPL stock, which has nearly tripled over the past five years and risen 600%+ over the past decade.
Fairfax Financial’s largest five stakes are BlackBerry, Resolute Forest Products, Kennedy-Wilson, USG, and Intrepid Potash. They together account for ~85% of the US long assets.
Warren Buffett's Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd , and confirmed it has become Apple Inc's second-largest shareholder.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
This article is part of a series that provides an ongoing analysis of the changes made to Berkshire Hathaway’s (NYSE:BRK.A) (NYSE:BRK.B) 13F stock portfolio on a quarterly basis. It is based on Warren Buffett’s regulatory 13F Form filed on 05/15/2018. Please visit our Tracking 10 Years Of Berkshire Hathaway's Investment Portfolio article series for an idea on how his holdings have progressed over the years and our previous update for the moves in Q4 2017.
Warren Buffett's Berkshire Hathaway reported larger holdings of the Israeli pharmaceutical company Teva Pharmaceutical and the St. Louis-based agricultural product giant Monsanto in the first quarter.
This is the second month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her combined dividend income totaled $1,300.03.
15h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
15h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET